% | $
Quotes you view appear here for quick access.

BioCryst Pharmaceuticals, Inc. Message Board

  • left2rightdoor left2rightdoor Jan 7, 2013 11:44 AM Flag

    Hepatitis treatments and how to improve after treatment failures

    Many of these articles show need for new treatment modalities.
    Articles: Hepatitis for January 7, 2013
    Ranked, sorted, and summarized by MDLinx editors from the latest literature
    7 new articles from 75 contributor journals scanned today (see the list)
    Efficacy and Safety of Pegylated Interferon Alfa–2a or Alfa–2b Plus Ribavirin for the Treatment of Chronic Hepatitis C in Children and Adolescents: A Systematic Review and Meta–analysis Evidence Based Medicine
    Clinical Infectious Diseases
    Update on the treatment of patients with non–genotype 1 HCV infection Review Article Evidence Based Medicine
    Clinical Infectious Diseases
    Tenofovir rescue therapy for chronic hepatitis B patients after multiple treatment failures Full Text
    World Journal of Gastroenterology
    The effectiveness of retreatment with peginterferon alfa and ribavirin in patients with chronic viral hepatitis C genotype 2 and 3: a prospective cohort study in Brazil Full Text
    BMC Infectious Diseases
    Efficacy of pegylated interferon alpha–2a AND alpha–2b in patients with genotype 1 chronic Hepatitis C: a meta–analysis Full Text Evidence Based Medicine
    BMC Infectious Diseases

    Cumulative viral evolutionary changes in chronic hepatitis B virus infection precedes hepatitis B e antigen seroconversion
    Current management and perspectives for HCV recurrence after liver transplantation
    Liver International

15.48+0.14(+0.91%)Jul 31 4:00 PMEDT